
Co 101244 hydrochloride
CAS No. 193356-17-1
Co 101244 hydrochloride( 4-Piperidinol, 1-[2-(4-hydroxyphenoxy)ethyl]-4-[(4-Methylphenyl)Methyl]-,hydrochloride )
Catalog No. M27615 CAS No. 193356-17-1
Co 101244 hydrochloride is an NR2B-containing NMDA receptor antagonist.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 87 | Get Quote |
![]() ![]() |
10MG | 143 | Get Quote |
![]() ![]() |
25MG | 290 | Get Quote |
![]() ![]() |
50MG | 462 | Get Quote |
![]() ![]() |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameCo 101244 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionCo 101244 hydrochloride is an NR2B-containing NMDA receptor antagonist.
-
DescriptionCo 101244 hydrochloride is an NR2B-containing NMDA receptor antagonist.(In Vitro):Co 101244 enhances neuroprotection and reduces NMDA-evoked Ca2+?elevations effectively .(In Vivo):Administration of 1 mg/kg s.c. Co 101244 displayed antidyskinetic effects with the reduction of 67% while sparing levodopa motor benefit.
-
In VitroCo 101244 effectively reduces NMDA-evoked Ca2+ elevations while enhancing neuroprotection.
-
In VivoCo 101244 (0.1, 1 mg/kg s.c.) displayed antidyskinetic effects (67 and 71% reduction, respectively) while sparing levodopa motor benefit.
-
Synonyms4-Piperidinol, 1-[2-(4-hydroxyphenoxy)ethyl]-4-[(4-Methylphenyl)Methyl]-,hydrochloride
-
PathwayMembrane Transporter/Ion Channel
-
TargetNMDAR
-
Recptorinhibitor of DNA binding (ID)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number193356-17-1
-
Formula Weight377.91
-
Molecular FormulaC21H28ClNO3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (264.62 mM)
-
SMILESCl.Cc1ccc(CC2(O)CCN(CCOc3ccc(O)cc3)CC2)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wojnarowicz PM, et al. A Small-Molecule Pan-Id Antagonist Inhibits Pathologic Ocular Neovascularization. Cell Rep. 2019 Oct 1;29(1):62-75.e7.
molnova catalog



related products
-
NMDA-IN-1
NMDA-IN-1 is a potent and NR2B-selective antagonist of NMDA(NMDA Ki of 0.85 nM; NR2B Ca2+ influx IC50 is 9.7 nM).
-
Neboglamine hydrochl...
Neboglamine (CR-2249, XY-2401) hydrochloride, an orally active positive modulator of the NMDA receptor glycine site, can be used in schizophrenia research .
-
Aptiganel
Aptiganel (CNS-1102) is a non-competitive NMDA antagonist, a peptide that may be used to study acute ischemic stroke.